27-Oct-2026 15:00:17
JUBILANT INGREVIA Q2: RECORD REVENUE UP 24% YOY; EBITDA SURGES 51%, MANAGEMENT EXPECTS GROWTH ACROSS ALL 3 SEGMENTS
• Revenue: Up 24% YoY to ₹1,394 Cr, highest-ever quarterly revenue • Growth Drivers: Stronger price realisations and stable sales volumes supported quarterly performance • FY27 Outlook: Management expects continued growth across all three business segments • Acetyls Business: Expects higher volumes supported by plant closures in Europe, creating potential market opportunities • CDMO Expansion: New Multi-Purpose Plant (MPP) on track for commissioning by year-end • Fine Chemicals: New manufacturing capacity expected to strengthen CDMO and Fine Chemicals growth opportunities • Order Pipeline: Robust business opportunity pipeline supports management's confidence in sustaining growth momentum • Operational Strength: Diversified sourcing, strong customer relationships and cost pass-through measures helped manage pricing volatility • Growth Strategy: Pinnacle transformation programme progressing well, supporting revenue growth and profitability improvement
JUBILANT INGREVIA LIMITED